Global prevalence of autism spectrum disorder and its gastrointestinal symptoms: A systematic review and meta-analysis

Wang, Jingyi; Ma, Bin; Wang, Jingjing; Zhang, Zeyi; Chen, Ou

doi:10.3389/fpsyt.2022.963102

Cited by 23 publications

(20 citation statements)

References 58 publications

(58 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three reviews all published in 2022 reported prevalence estimates of ASD DHD that ranged from 0.6% (95% CI: 0.4–1.0) to a median of 1.0% (Interquartile range: 1.1–4.4) ( 11 , 24 , 25 ). One study by Barican et al reported estimates for ADHD and ASD, but the estimate for ASD was not considered as it was derived from only four primary studies ( 23 ).…”

Section: Resultsmentioning

confidence: 99%

“…The primary studies covered ranged from 51 to 71 articles derived from 25 to 41 countries, less than half of which were LMICs in all three reviews. One of the reviews by Wang et al aimed to determine the prevalence of gastrointestinal symptoms in individuals with ASD and reported pooled estimates of ASD for HICs (0.9%, 95% CI: 0.8–1.2) and LMICs (1.6%, 95% CI: 1.1–2.0) ( 25 ). Four of the 51 primary studies in this review involved individuals older 20 years or older and the selected studies were published between 2001 and 2022.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review

Olusanya

Smythe

Ogbo

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

AimThe provisions of the United Nation's Sustainable Development Goals (SDGs) for disability-inclusive education have stimulated a growing interest in ascertaining the prevalence of children with developmental disabilities globally. We aimed to systematically summarize the prevalence estimates of developmental disabilities in children and adolescents reported in systematic reviews and meta-analyses.MethodsFor this umbrella review we searched PubMed, Scopus, Embase, PsycINFO, and Cochrane Library for systematic reviews published in English between September 2015 and August 2022. Two reviewers independently assessed study eligibility, extracted the data, and assessed risk of bias. We reported the proportion of the global prevalence estimates attributed to country income levels for specific developmental disabilities. Prevalence estimates for the selected disabilities were compared with those reported in the Global Burden of Disease (GBD) Study 2019.ResultsBased on our inclusion criteria, 10 systematic reviews reporting prevalence estimates for attention-deficit/hyperactivity disorder, autism spectrum disorder, cerebral palsy, developmental intellectual disability, epilepsy, hearing loss, vision loss and developmental dyslexia were selected from 3,456 identified articles. Global prevalence estimates were derived from cohorts in high-income countries in all cases except epilepsy and were calculated from nine to 56 countries. Sensory impairments were the most prevalent disabilities (approximately 13%) and cerebral palsy was the least prevalent disability (approximately 0.2–0.3%) based on the eligible reviews. Pooled estimates for geographical regions were available for vision loss and developmental dyslexia. All studies had a moderate to high risk of bias. GBD prevalence estimates were lower for all disabilities except cerebral palsy and intellectual disability.ConclusionAvailable estimates from systematic reviews and meta-analyses do not provide representative evidence on the global and regional prevalence of developmental disabilities among children and adolescents due to limited geographical coverage and substantial heterogeneity in methodology across studies. Population-based data for all regions using other approaches such as reported in the GBD Study are warranted to inform global health policy and intervention.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review

Olusanya

Smythe

Ogbo

et al. 2023

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…ASD is more common in men than in women. [5] The frequency of autism worldwide found convincing indication for health discrepancies that affects deprived communities. There is a need to strengthen level of awareness and procedure to report these inequalities globally.…”

Section: Introductionmentioning

confidence: 99%

Autism Spectrum Disorder (ASD): A Nursing Imperative

Sampayan

Pavuthakursar

Bhagavathy

2023

Int J Sci Healthcare Res

View full text Add to dashboard Cite

There is a growing concern about the increased global prevalence of children with autism spectrum disorder (ASD). A report published in autism research revealed that about 100 in 10,000 children around the world are diagnosed with autism spectrum disorder (ASD). The significant rise in ASD raises massive concerns among healthcare professionals. In the nursing profession, caring for autistic children is a challenging role. Nurses must especially address their needs. Implementing the nursing process requires an in-depth understanding of the behaviors demonstrated by children with ASD. In other words, to become more effective among these vulnerable groups, special training is needed to respond to their needs holistically. Nurses should recognize that children with ASD require individual assessment and treatment. The nursing assessment must note developmental delays and behavioral issues including speech and language abilities. Through detailed assessment, nurses can address the nursing problem and plan care appropriately. Nurses must work closely with the family in the implementation of care. The activity of daily living, health priority needs, and safety among children with ASD are evaluation measures that must be given with utmost importance. Caring for children with ASD requires appropriate nursing interventions. Nurses can become an agent of change, an educator, and an advocator. This present article highlighted nursing roles in the care of children with autism. It emphasized the nursing imperative in recognizing patients' health needs and identification of concerns with children's families. In particular, nurses must demonstrate responsibility in achieving desirable outcomes for children with ASD. Keywords: Autism Spectrum Disorder (ASD), Nursing Imperative for ASD

show abstract

“…Many autistic people have co-occurring mental and physical health conditions that impact quality of life, such as depression, anxiety, gastrointestinal symptoms, and epilepsy (7)(8)(9)(10)(11)(12).…”

Section: Introductionmentioning

confidence: 99%

European Autism GEnomics Registry (EAGER): Protocol for a multicentre cohort study and registry

Bloomfield,

Lautarescu,

Heraty

et al. 2023

Preprint

View full text Add to dashboard Cite

Introduction: Autism is a common neurodevelopmental condition with a complex genetic aetiology that includes contributions from monogenic and polygenic factors. Many autistic people have unmet healthcare needs that could be served by genomics-informed research and clinical trials. The primary aim of the European Autism GEnomics Registry (EAGER) is to establish a registry of participants with a diagnosis of autism or an associated rare genetic condition who have undergone whole-genome sequencing. The registry can facilitate recruitment for future clinical trials and research studies, based on genetic, clinical, and phenotypic profiles, as well as participant preferences. The secondary aim of EAGER is to investigate the association between mental and physical health characteristics and genetic profiles. Methods and analysis: EAGER is a European multisite cohort study and registry and is part of the AIMS-2-TRIALS consortium. EAGER was developed with input from the AIMS-2-TRIALS Autism Representatives and representatives from the rare genetic conditions community. 1,500 participants with a diagnosis of autism or an associated rare genetic condition will be recruited at 13 sites across 8 countries. Participants will give a blood or saliva sample for whole-genome sequencing and answer a series of online questionnaires. Participants may also consent for the study to access pre-existing clinical data. Participants will be added to the EAGER registry. Data will be shared via the Autism Sharing Initiative, a new international collaboration aiming to create a federated system for autism data sharing. Ethics and dissemination: EAGER has received full ethical approval from ethics committees in the UK (REC 23/SC/0022), Germany (S-375/2023), Portugal (CE-085/2023) and Spain (HCB/2023/0038, PIC-164-22). Approvals are in the process of being obtained from committees in Italy, Sweden, Ireland, and France. Findings will be disseminated via scientific publications and conferences, but also beyond to participants and the wider community (e.g., the AIMS-2-TRIALS website, stakeholder meetings, newsletters).

show abstract

Global prevalence of autism spectrum disorder and its gastrointestinal symptoms: A systematic review and meta-analysis

Cited by 23 publications

References 58 publications

Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review

Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review

Autism Spectrum Disorder (ASD): A Nursing Imperative

European Autism GEnomics Registry (EAGER): Protocol for a multicentre cohort study and registry

Contact Info

Product

Resources

About